Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
HyperTrap Heparin HP Column for Assay Design
2026-08-26
The HyperTrap Heparin HP Column supports assay-aware enrichment of heparin-binding biomolecules for signaling and protein studies. This article connects column chemistry with causal experimental design, using CCR7–Notch1 stemness research to define practical fractionation, controls, and limitations.
-
S-Nitrosylation and Aluminum Resistance in Arabidopsis
2026-08-25
A 2026 Molecular Plant study identifies nitric oxide–dependent S-nitrosylation as a coordinated regulatory mechanism linking external and internal aluminum detoxification in Arabidopsis. The work shows that modification of STOP1 and STAR1 has opposite effects on protein stability, offering a mechanistic explanation for how plants balance malate secretion with vacuolar aluminum sequestration.
-
Wnt agonist 1: Assay Workflows and Optimization
2026-08-25
Wnt agonist 1, also called BML-284, provides a defined small-molecule route to β-catenin-dependent transcription for differentiation, developmental, and cancer pathway studies. This practical guide connects dose-controlled Wnt signaling pathway activation with mechanistic chemoresistance assays while emphasizing controls, solvent handling, and interpretation limits.
-
Heparin Sodium in Coagulation Assay Workflows
2026-08-24
Heparin sodium provides a practical, water-soluble platform for modeling antithrombin-dependent inhibition of thrombin and factor Xa in thrombosis studies. This guide also shows how to use anticoagulation controls when investigating plant-derived nanovesicle uptake, while separating established coagulation measurements from exploratory cell-surface competition experiments.
-
Ciprofloxacin Hydrochloride: Mechanism & Evidence
2026-08-24
Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV. Evidence also supports model-specific immunomodulatory effects and shows that tetracycline can antagonize ciprofloxacin-associated bacterial killing through increased survival of low-SOS cells.
-
ONC201 in H3K27M Diffuse Midline Glioma
2026-08-23
This study links ONC201 activity in H3K27M-mutant diffuse midline glioma to coordinated metabolic and epigenetic remodeling rather than to a single molecular endpoint. Clinical outcomes, tumor sequencing, cultured-cell experiments, and cerebrospinal fluid analyses indicate that treatment-associated 2-hydroxyglutarate accumulation may help restore H3K27me3 and suppress programs supporting tumor proliferation.
-
Leucovorin Calcium in Gastric Cancer Assembloids
2026-08-22
Use Leucovorin Calcium as a mechanistic rescue control in patient-derived gastric cancer assembloids, not merely as a folate supplement. A matched organoid–stroma workflow can reveal when tumor microenvironment composition changes methotrexate response and antifolate resistance phenotypes.
-
CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness
2026-08-22
The reference study identifies functional crosstalk between CCR7 and Notch1 in stem-like cells derived from MMTV-PyMT mammary tumors, showing that CCR7 stimulation activates Notch signaling and supports cancer stem-like behavior. Its findings provide a mechanistic basis for considering the two signaling axes together, while also highlighting the need to distinguish pathway evidence from therapeutic validation.
-
Direct Mouse Genotyping Kit for Assay Integrity
2026-08-21
The Direct Mouse Genotyping Kit enables rapid PCR amplification from mouse tissue without conventional DNA purification. This guide explains how to build a more reliable genotype-to-phenotype workflow, informed by recent CRISPR and RNA-splicing research.
-
Rack1, Ferroptosis, and Hindgut Development in ARM
2026-08-20
A 2024 Cell Proliferation study uses spatial transcriptomics and mechanistic validation to connect reduced Rack1 expression with ferroptotic injury during hindgut development in an ethylenethiourea-induced rat model of anorectal malformation. The work identifies a Rack1–p38-MAPK–Nqo1/Gpx4 axis that links developmental patterning with iron-dependent oxidative cell death and suggests experimental strategies for testing this relationship.
-
Temafloxacin: Mechanism, Assays & Limits
2026-08-20
Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent used in laboratory studies of Gram-positive and Gram-negative bacterial infections. Its reported pathogen-specific MICs, assay concentrations, solvent behavior, and historical pharmacokinetic data support controlled research workflows rather than unsupervised clinical use.
-
Thrombin B Chain: From Clotting to Translational Insight
2026-08-19
Thrombin is a central trypsin-like serine protease, but sequence-defined B-chain fragments should not be treated as interchangeable with catalytically active full-length enzyme. This article connects thrombin biology with fibrin-matrix angiogenesis, experimental validation, reagent selection, and translational study design.
-
SN-38 Blocks FUBP1–FUSE Binding
2026-08-19
The reference study identifies a mechanism beyond canonical topoisomerase I poisoning: camptothecin and SN-38 also disrupt binding of the oncogenic transcriptional regulator FUBP1 to the single-stranded FUSE element. Biochemical screening and hepatocellular carcinoma cell experiments suggest that FUBP1–FUSE interference may contribute to the antitumor activity of SN-38 and inform future mechanism-focused studies.
-
Doxycycline at the Mechanobiology–Translation Interface
2026-08-18
A translational framework for using Doxycycline as a mechanopharmacology perturbation in 3D hydrogel, stem cell, and cancer research—while separating established evidence from testable hypotheses.
-
Ginsenoside Rg1: Applied Neuroimmune Workflows
2026-08-18
Ginsenoside Rg1 is a practical perturbation tool for connecting behavioral, synaptic, inflammatory, and gut-barrier readouts in neuroprotection research. This workflow translates Treg-dependent anesthesia findings into reproducible assay design, chemical handling, and troubleshooting decisions.